Arcadia Biosciences (Arcadia Biosciences) Total Stockholders Equity : $12.84 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Arcadia Biosciences Total Stockholders Equity?

Arcadia Biosciences's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $12.84 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Arcadia Biosciences's Book Value per Share for the quarter that ended in Dec. 2023 was $9.99. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Arcadia Biosciences's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.08.

Arcadia Biosciences Total Stockholders Equity Historical Data

The historical data trend for Arcadia Biosciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arcadia Biosciences Total Stockholders Equity Chart

Arcadia Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

7.71

27.73

31.09

21.03

12.84

Arcadia Biosciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															21.03	16.83	17.87	15.54	12.84

Arcadia Biosciences (NAS:RKDA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Arcadia Biosciences's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(12.841	-	0)	/	1.28534
	=	9.99

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Arcadia Biosciences's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.852	+	0.155)	/	12.841
	=	0.08

Arcadia Biosciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Arcadia Biosciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Arcadia Biosciences (Arcadia Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Arcadia Biosciences Inc (NAS:RKDA) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

17D:Germany 17D:Germany

Address

5950 Sherry Lane, Suite 215, Dallas, TX, USA, 75225

Website

https://www.arcadiabio.com

Arcadia Biosciences Inc is a producer and marketer of innovative, plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements primarily in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care.

Executives

Thomas J. Schaefer	officer: Chief Financial Officer	202 COUSTEAU PLACE STE 105, DAVIS CA 95618
Stanley Jr Jacot	officer: Chief Executive Officer	202 COUSTEAU PLACE STE 105, DAVIS CA 95618
Pamela Haley	officer: Chief Financial Officer	202 COUSTEAU PLACE, DAVIS CA 95618
Laura Pitlik	officer: Chief Marketing Officer	202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Chris Cuvelier	officer: Chief Growth Officer	202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Deborah D Carosella	director	3603 HAVEN AVE, SUITE E, MENLO PARK CA 94025
Matthew T Plavan	officer: Chief Financial Officer	C/O THERMOGENESIS CORP., 2711 CITRUS ROAD, RANCHO CORDOVA CA 95742
Randall Shultz	officer: Chief Technology Officer	4222 E. THOMAS ROAD, SUITE 320, PHOEBIIX AZ 85018
Sarah Reiter	officer: Chief Commercial Officer	202 COUSTEAU PLACE, DAVIS CA 95618
Lilian Shackelford Murray	director	228 BEACH ROAD, BELVEDERE CA 94920
Kevin Comcowich	director	C/O ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Albert D. Bolles	director	CONAGRA FOODS, INC., ONE CONAGRA DRIVE, MS 1-330, OMAHA NE 68102
Eric J. Rey	director, officer: President and CEO	ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Zhongjin Lu	officer: VP Product Development	ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Amy Yoder	director	C/O SPECTRUM BRANDS, INC., 6 CONCOURSE PARKWAY, SUITE 3300, ATLANTA GA 30328